nu image semaglutide Medical (@NuImageMedical) • Facebook nu image semaglutide Weight-loss anarchy
Description
When sugar is low, it reverses course
Retatrutide is a next-generation weight loss injection developed by Eli Lilly (same manufacturer as Mounjaro), designed to target three separate hormone receptors in the body: the GLP-1 receptor, the GIP receptor, and the glucagon receptor
Stress affects your hormones
Safety Considerations and Maximum Dose Boundaries The 2.4 mg weekly maximum is an evidence-based boundary established through FDA-approved clinical trials for semaglutide weight management
